2-{[(1R,2S)-2-Aminocyclohexyl]amino}-6-(3-methylanilino)pyridine-3-carbonitrile

ID: ALA4455291

PubChem CID: 155525161

Max Phase: Preclinical

Molecular Formula: C19H23N5

Molecular Weight: 321.43

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1cccc(Nc2ccc(C#N)c(N[C@@H]3CCCC[C@@H]3N)n2)c1

Standard InChI:  InChI=1S/C19H23N5/c1-13-5-4-6-15(11-13)22-18-10-9-14(12-20)19(24-18)23-17-8-3-2-7-16(17)21/h4-6,9-11,16-17H,2-3,7-8,21H2,1H3,(H2,22,23,24)/t16-,17+/m0/s1

Standard InChI Key:  HDHMAGKLWCYAGI-DLBZAZTESA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   13.9404  -17.6026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9392  -18.4221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6473  -18.8311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3569  -18.4217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3541  -17.5990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6455  -17.1937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0580  -17.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7642  -16.7753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0653  -18.8291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0666  -19.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3565  -20.0512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3558  -20.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0624  -21.2761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7713  -20.8677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7736  -20.0479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4804  -19.6378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2312  -18.8302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2305  -19.6474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5224  -20.0538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5214  -20.8703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2293  -21.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9397  -20.8678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9372  -20.0527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8132  -21.2780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  3  0
  5  7  1  0
  4  9  1  0
 10  9  1  1
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  1
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 20 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4455291

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 321.43

Molecular Weight (Monoisotopic): 321.1953

AlogP: 3.69

#Rotatable Bonds: 4

Polar Surface Area: 86.76

Molecular Species: BASE

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.92

CX LogP: 3.84

CX LogD: 1.44

Aromatic Rings: 2

Heavy Atoms: 24

QED Weighted: 0.80

Np Likeness Score: -1.33

References

1. Taniguchi T, Inagaki H, Baba D, Yasumatsu I, Toyota A, Kaneta Y, Kiga M, Iimura S, Odagiri T, Shibata Y, Ueda K, Seo M, Shimizu H, Imaoka T, Nakayama K..  (2019)  Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.,  10  (5): [PMID:31097992] [10.1021/acsmedchemlett.8b00631]

Source

Source(1):

• Scientific Literature